Frontlight ResearchEarly access
Trial site
Tokai University Hospital
- 10running trials
- 4closed trials
The trials here
What the 14 trials at this site are about, from their registry records.
- Conditions
- Acute lymphoblastic leukaemia2 trials
- Deep vein thrombosis and pulmonary embolism2 trials
- Diffuse large B-cell lymphoma2 trials
- Fatty liver disease (MASLD/MASH)2 trials
- Multiple myeloma2 trials
- Psoriasis2 trials
- Acute myeloid leukaemia1 trial
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Follicular lymphoma1 trial
- Hodgkin lymphoma1 trial
- Liver cirrhosis1 trial
- and 4 more
- Phase
- Phase 310 trials
- Phase 1/22 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting6 trials
- Active, not recruiting4 trials
- Completed3 trials
- Terminated1 trial
- Lead sponsor
- Regeneron Pharmaceuticals3 trials
- Amgen2 trials
- Boehringer Ingelheim2 trials
- Hoffmann-La Roche1 trial
- Japanese Gynecologic Oncology Group1 trial
- and 5 more
Running trials
Recruiting
Recruiting
REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Fatty liver disease (MASLD/MASH)2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Acute myeloid leukaemia1 recruiting
- Childhood cancers1 recruiting
- Liver cirrhosis1 recruiting
- Multiple myeloma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Ovarian cancer1 recruiting
Closed trials
Completed
Completed
Terminated
Safety and Efficacy Study of OPC-415 in Patients With Relapsed and/or Refractory Multiple Myeloma
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026